Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancer. [electronic resource]
Producer: 20100921Description: 409-14 p. digitalISSN:- 1872-8332
- Administration, Oral
- Adult
- Aged
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Disease Progression
- Docetaxel
- Drug Combinations
- Drug Dosage Calculations
- Drug Therapy, Combination
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Neutropenia -- etiology
- Oxonic Acid -- administration & dosage
- Survival Analysis
- Taxoids -- administration & dosage
- Tegafur -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.